RecruitingNot ApplicableNCT07420426

Instant Message-delivered Personalised Acceptance and Commitment Therapy (IMPACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment

Instant Message-delivered Personalised Acceptance and Commitment Therapy (IMPACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment: a Mixed Methods Study


Sponsor

The University of Hong Kong

Enrollment

160 participants

Start Date

Dec 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to develop an automated instant message-delivered intervention (i.e., EMI) for people with mild cognitive impairment, and to investigate the feasibility and effectiveness of the intervention.


Eligibility

Min Age: 50 Years

Inclusion Criteria7

  • Community-dwelling adults aged ≥ 50 years
  • HK-MoCA score ranged from 18 to 22
  • MBI-C ≥7
  • SCD-9 ≥3
  • IADL <18
  • Able to read and communicate in Chinese
  • Able to use the text or voice messaging function on a smartphone

Exclusion Criteria5

  • Clinical diagnosis of dementia
  • Clinical diagnosis of psychiatric disease
  • Currently participating in any type of psychological or behavioural intervention for NPSs
  • Currently taking psychiatric medication
  • Currently receiving acute care or post-acute hospitalization care

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALautomated instant message-guided neuropsychiatric symptoms management

Participants in intervention group will receive the EMI for 9 weeks. Based on the steps of mobile message development recommended by Abroms, et al., we will develop a message content library and protocol for EMI delivery.

BEHAVIORALgeneral mental health management

Participants in control group will receive the messages for 8 weeks.The control group will receive instant messages about general mental health management from the HKSAR Government website, which is open to the public (https://www.shallwetalk.hk/en/mental-well-being/mental-well-being-is-related-to-you/), with reminder text messages of follow-up surveys.


Locations(1)

The University of Hong Kong

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07420426


Related Trials